BETA vs REGN
Beta Technologies, Inc. (BETA) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Beta Technologies, Inc. (BETA) is a aerospace & defense company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BETA revenue for 2025-09-30 was $8.9M. Net income was -$437.2M. Revenue was up 190.9% from 2024-09-30 to 2025-09-30. BETA currently screens at market cap $3.72B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BETA currently screens at market cap $3.72B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BETA and REGN stock pages for the full models.
Not investment advice.